Reagents for detection of Mycobacterium Tuberculosis: Liaison QuantiFERON TB Gold Plus and LIAISON Control QuantiFERON TB Gold Plus

This sole-source, firm-fixed-price, 5-year IDIQ contract will procure QuantiFERON TB Gold-Plus assay reagents for latent tuberculosis testing at Madigan Army Medical Center (MAMC). The reagents must be FDA-cleared, fully automated, compatible with the DiaSorin LIAISON XL analyzer, and provide both qualitative and quantitative (IU/mL) results directly to the LIS. The assays must align with existing Defense Health Agency (DHA) laboratory operations and reference testing mandates, including established specimen collection procedures and reporting in MHS Genesis. Due to MAMC's existing infrastructure and operational requirements, only QuantiFERON TB Gold-Plus reagents meet the government's needs for continuity of operations and testing capacity.

Notice ID

eb7e8e8c431d42a396fc15f7bb3eb17e

Solicitation Number

W81K0225QA107

NAICS Code

325413

Classification Code

6550